NEUMOLOGÍA PEDIÁTRICA

56 / 64

100 Contenido disponible en
PREVENCIÓN
La educación médica al personal y la familia sobre prevención
son fundamentales. Los niños no deben ser fumadores pasi-
vos. Y el lavado de manos luego del contacto con el paciente
debe ser una conducta obligatoria y rutinaria(46,56,57). El uso de
Palivizumab, está ampliamente recomendado como anticuer-
po monoclonal dirigido contra las glicoproteínas de la super-
ficie del VRS, específicamente contra el epítope A de la glico-
proteína F del VRS. La vía de administración es intramuscular,
y la dosis recomendada es 15 mg/kg. Se recomiendan cinco
dosis totales, a los 0, 1, 2, 3 y 4 meses. No debe ser utilizado
en infección aguda, pero un episodio previo de bronquiolitis
no contraindica su uso. Las indicaciones actuales para su
uso son pacientes menores de 24 meses con enfermedad
pulmonar crónica o cardiopatía congénita, antecedente de
prematurez menor de 32 semanas, o aquel prematuro entre
las 32 y 35 semanas de edad gestacional que convivan con un
menor de 5 años o asistan a jardín infantil(57).
REFERENCIAS
1. McConnochie KM. Bronchiolitis. What’s in the name? Am J Dis
Child 1983; 137: 11-3.
2. McConnochie KM, Roghmann KJ. Predicting clinically significant
lower respiratory tract illness in childhood following mild
bronchiolitis. Am J Dis Child 1985; 139: 625.
3. González de Dios J, Ochoa Sangrador C; Grupo de revisión y
panel de expertos de la Conferencia de Consenso del Proyecto
abreviado (Bronquiolitis-Estudio de Variabilidad, Idoneidad y
Adecuación). Consensus conference on acute bronchiolitis (I):
methodology and recommendations. An Pediatr (Barc) 2010; 72:
221.e1-e33
4. Wohl ME. Bronchiolitis. In: Chernick V, Boat TF, Wilmot RW,
Bush A, editors. Disorders of the respiratory tract in children.
Philadelphia: Saunders Elsevier; 2006. p. 423-32.
5. Wagner T. Bronchiolitis. Pediatr Rev 2009; 30 (10): 386-95.
6. Mansbach JM, Pelletier AJ, Camargo CA Jr. US outpatient office
visits for bronchiolitis, 1993-2004. Ambul Pediatr 2007; 7: 304.
7. Ucrós S, Dueñas EM, Gutiérrez ML. Calendario y variación
estacional de las afecciones respiratorias en la ciudad de Santafé de
Bogotá. Rev Colomb Neumol 1997; 9: 124-32.
8. Figueras-Aloy J, Carbonell-Estrany X, Quero J; IRIS Study Group.
Case-control study of the risk factors linked to respiratory syncytial
virus infection requiring hospitalization in premature infants born
at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J
2004; 23 (9): 815-20.
9. Choudhuri JA, Ogden LG, Ruttenber AJ, Thomas DS, Todd JK,
Simoes EA. Effect of altitude on hospitalizations for respiratory
syncytial virus infection. Pediatrics 2006 ;117 (2): 349-56.
10. Greensill J, McNamara PS, Dove W, Flanagan B, Smyth RL, Hart
CA. Human metapneumovirus in severe respiratory syncytial virus
bronchiolitis. Emerg Infect Dis 2003; 9 (3): 372-5.
11. Kuypers J, Martin ET, Heugel J, Wright N, Morrow R, Englund
JA. Clinical disease in children associated with newly described
coronavirus subtypes. Pediatrics 2007; 119 (1): e70-6.
12. Kristoffersen AW, Nordbø SA, Rognlien AG, Christensen A, Døllner
H. Coronavirus causes lower respiratory tract infections less
frequently than RSV in hospitalized Norwegian children. Pediatr
Infect Dis J 2011; 30 (4): 279-83.
13. Calvo C, García-García ML, Pozo F, Carvajal O, Pérez-Breña
P, Casas I. Clinical characteristics of human bocavirus infections
compared with other respiratory viruses in Spanish children. Pediatr
Infect Dis J 2008; 27 (8): 677-80.
14. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl
J Med 2001; 344 (25): 1917-28.
15. Coffin SE. Bronchiolitis: in-patient focus. Pediatr Clin North Am
2005; 52 (4): 1047-57.
16. Handforth J, Friedland JS, Sharland M. Basic epidemiology and
inmunopathology of RSV in children. Paediatr Respir Rev 2000; 1
(3): 210-4.
17. Willson DF, Landrigan CP, Horn SD, Smout RJ. Complications in
infants hospitalized for bronchiolitis or respiratory syncytial virus
pneumonia. J Pediatr 2003; 143 (5 Suppl): S142-9.
18. Meléndez E, Harper MB. Utility of sepsis evaluation in infants 90
days of age or younger with fever and clinical bronchiolitis. Pediatr
Infect Dis J 2003; 22 (12): 1053-6.
19. González Caballero D, González Pérez-Yarza E. Bronquiolitis
aguda: bases para un protocolo racional. An Esp Pediatr 2001; 55:
355-364.
20. Arias AE. Bronquiolitis [Internet]. Argentina: Web Médica
Argentina; 2003 [citada 2013 Jun 07]. Disponible en: http://www.
21. Petruzella FD, Gorelick MH. Duration of illness in infants with
bronchiolitis evaluated in the emergency department. Pediatrics
2010; 126 (2): 285-90.
22. Bilavsky E, Shouval DS, Yarden-Bilavsky H, Fisch N, Ashkenazi
S, Amir J. A prospective study of the risk for serious bacterial
infections in hospitalized febrile infants with or without bronchiolitis.
Pediatr Infect Dis J 2008; 27 (3): 269-70.
23. Eisenhut M. Extrapulmonary manifestations of severe respiratory
syncytial virus infection-a systematic review. Crit Care 2006; 10 (4):
R107.
24. American Academy of Pediatrics Subcommittee on Diagnosis
and Management of Bronchiolitis. Diagnosis and management of
bronchiolitis. Pediatrics 2006; 118: 1774-93.
25. Wang EE, Law BJ, Stephens D. Collaborative Network on
Infections in Canada (PICNIC) prospective study of risk factors and
outcomes in patients hospitalized with respiratory syncytial viral
lower respiratory tract infection. J Pediatr 1995; 126: 212-9.
26. Esposito S, Salice P, Bosis S, Ghiglia S, Tremolati E, Tagliabue
C, et al. Altered cardiac rhythm in infants with bronchiolitis and
respiratory syncytial virus infection. BMC Infect Dis 2010; 10: 305.
27. Kho N, Kerrigan JF, Tong T, Browne R, Knilans J. Respiratory
syncytial virus infection and neurologic abnormalities: retrospective
cohort study. J Child Neurol 2004; 19: 859-64.
28. Randolph AG, Reder L, Englund JA. Risk of bacterial infection in
previously health respiratory syncytial virus-infected young children
admitted to the intensive care unit. Pediatr Infect Dis J 2004; 23:
990-4.
29. Bordley WC, Viswanathan M, King VJ, Sutton SF, Jackman AM,
Sterling L, et al. Diagnosis and testing in bronchiolitis: a systematic
review. Arch Pediatr Adolesc Med 2004; 158 (2): 119-26.
30. Macfarlane P, Denham J, Assous J, Hughes C. RSV testing in
bronchiolitis: which nasal sampling method is best?. Arch Dis Child
2005; 90 (6): 634-5.
31. Schuh S, Lalani A, Allen U, Manson D, Babyn P, Stephens D, et
Neumol Pediatr 2013; 8 (2): 95-101. Bronquiolitis: artículo de revisión - Parra A. et al